Skip to main content

Abstract

This chapter discusses the evaluation of stability data. It follows the \hbox{stability} study information from the point that raw data is generated in the lab, calculations are performed to give test results, and test results are entered in the stability summary sheets, until data is finally entered into a stability report for submission purposes. This chapter also includes a summary of data evaluation addressed in ICH Q1E and a discussion of Out-of-Specification (OOS) and Out-of-Trend (OOT) investigations. Specification setting and shelf-life extrapolation, which are performed after evaluating stability data, are also described in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. International Conference on Harmonization (2003) Q1A(R2): Stability testing of new drug substances and products (second revision).

    Google Scholar 

  2. International Conference on Harmonization (2003) Q1E: Evaluation of stability data.

    Google Scholar 

  3. PhRMA CMC Statistics and Stability Expert Teams (April 2003) Identification of out-of-trend stability results. Pharm Technol pp 38–52.

    Google Scholar 

  4. FDA (1998) Guide to inspection of quality control laboratories.

    Google Scholar 

  5. FDA/CDER (October 2006) Guidance for industry: Investigating out-of-specification (OOS) test results for pharmaceutical production.

    Google Scholar 

  6. International Conference on Harmonization (1999) Q6A: Specifications: test procedures and acceptance criteria for new drug substances and new drug products: chemical substances.

    Google Scholar 

  7. International Conference on Harmonization (1999) Q6B: Specifications: test procedures and acceptance criteria for biotechnological/biological products.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nanda Subbarao .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Subbarao, N., Huynh-Ba, K. (2009). Evaluation of Stability Data. In: Huynh-Ba, K. (eds) Handbook of Stability Testing in Pharmaceutical Development. Springer, New York, NY. https://doi.org/10.1007/978-0-387-85627-8_13

Download citation

Publish with us

Policies and ethics